1. Home
  2. GITS vs TOVX Comparison

GITS vs TOVX Comparison

Compare GITS & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GITS
  • TOVX
  • Stock Information
  • Founded
  • GITS 2018
  • TOVX 2001
  • Country
  • GITS South Korea
  • TOVX United States
  • Employees
  • GITS N/A
  • TOVX N/A
  • Industry
  • GITS
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GITS
  • TOVX Health Care
  • Exchange
  • GITS Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • GITS 4.8M
  • TOVX 4.0M
  • IPO Year
  • GITS N/A
  • TOVX 2006
  • Fundamental
  • Price
  • GITS $1.17
  • TOVX $1.41
  • Analyst Decision
  • GITS
  • TOVX Strong Buy
  • Analyst Count
  • GITS 0
  • TOVX 1
  • Target Price
  • GITS N/A
  • TOVX $6.00
  • AVG Volume (30 Days)
  • GITS 86.4K
  • TOVX 21.6K
  • Earning Date
  • GITS 11-20-2024
  • TOVX 05-06-2025
  • Dividend Yield
  • GITS N/A
  • TOVX N/A
  • EPS Growth
  • GITS N/A
  • TOVX N/A
  • EPS
  • GITS N/A
  • TOVX N/A
  • Revenue
  • GITS N/A
  • TOVX N/A
  • Revenue This Year
  • GITS N/A
  • TOVX N/A
  • Revenue Next Year
  • GITS N/A
  • TOVX N/A
  • P/E Ratio
  • GITS N/A
  • TOVX N/A
  • Revenue Growth
  • GITS 85.47
  • TOVX N/A
  • 52 Week Low
  • GITS $0.10
  • TOVX $0.96
  • 52 Week High
  • GITS $5.06
  • TOVX $12.25
  • Technical
  • Relative Strength Index (RSI)
  • GITS N/A
  • TOVX 58.99
  • Support Level
  • GITS N/A
  • TOVX $1.28
  • Resistance Level
  • GITS N/A
  • TOVX $1.47
  • Average True Range (ATR)
  • GITS 0.00
  • TOVX 0.13
  • MACD
  • GITS 0.00
  • TOVX 0.03
  • Stochastic Oscillator
  • GITS 0.00
  • TOVX 87.13

About GITS Global Interactive Technologies Inc. Common Stock

Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: